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Ischemic preconditioning was described first 
by Murry et al in 1986 in patients with coronary artery 
disease and was described as a phenomenon which 
"could delay cell death through multiple anginal 
episodes after coronary occlusion" and hence, 
increase resistance of the myocardial tissues towards 
ischemia (1). 
Ischemic preconditioning is defined as a 
stumbled or halted perfusion of a specific organ 
after a pause in perfusion; in other words, it is a 
reperfusion after a transient perfusion pause which 
goes up to a sub-lethal degree of insult and could 
improve the recruitment of the tissue at risk of 
ischemia; it is generally believed that mitochondria 
are the main target of chemical conditioning in 
ischemic preconditioning (2-4). 
Though the first discovery included direct 
preconditioning, the next experiences demonstrated 
another effect later known as remote ischemic 
preconditioning which implies the effects of 
ischemic burden on one organ protecting another 
organ so called "remote organ" (5, 6).  
A number of mechanisms have been 
implicated as the underlying mechanism for ischemic 
preconditioning (both local and remote 
preconditioning) in different organs, including but 
not limited to (2-4, 7): 
 ATP-sensitive K+ (K(ATP)) channels 
 mitogen-activated protein kinase (MAPK) 
 protein kinase C (PKC) 
 astrocytic Toll-like receptor 3 
 adenosine 
 and a number of other intracellular signaling 
pathways 
Though a considerable bulk of research have 
been published in favor of ischemic preconditioning 
and remote conditioning, there are still main 
controversies, especially about patients undergoing 
cardiac surgery (6, 8, 9). However, Deng et al 
performed a meta-analysis and demonstrated that limb 
remote ischemic preconditioning reduces the size of 
myocardial damage in patients undergoing cardiac 
surgery (10). These studies challenge some of the 
beliefs about ischemic preconditioning, including all 
its variants, namely remote and delayed 
preconditioning. In this volume of the Journal, 
Jamshidi et al, have studied the effects of remote 
ischemic preconditioning in lower extremity 
orthopedic surgeries on hemodynamic and respiratory 
and have shown that " remote ischemic 
preconditioning may reduce increases in systolic blood 
pressure and acidosis following tourniquet application" 
(11). The study by Jamshidi et al, though is not the final 
word about "the role of remote ischemic 
preconditioning in noncardiac surgeries" gives us a 
good clue for further studies assessing the possible 
merits of remote ischemic preconditioning. However, 
the final word is not uttered yet. 
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